Stem Cell Therapy

Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based...

Founded in 2004
Total money raised: $74.4M

28760 Calle Marconi, 1
Parque Tecnológico de Madrid, Tres Cantos


Phone: +34 91 804 92 64

Updated on Mar 11, 2010
Cellerix at CrunchBase
Eduardo Bravo CEO
Claudia D'Augusta CFO
Claudia D’Augusta CFO
Joachim Rothe Board Member
Joel Jean Mairet Board Chairman

January, 2010

Cellerix raised $37.7M in a Series C round from Ysios Capital, Life Sciences Partners, Ventech, Grupo Genetrix, Roche Venture Fund, and Novartis Venture Fund

Cellerix, SL: Series C $37.7M

September, 2007

Cellerix raised $36.7M in a Series B round from Life Sciences Partners, Ventech, Ysios Capital, Roche Venture Fund, Novartis Venture Fund, and Biopartners Capital

Cellerix closes €27,2m financing round to bring product Cx401 to market


Cellerix was founded in 2004